The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
about
Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signalingEMT in Breast Carcinoma-A ReviewPancreatic cancer stem cell markers and exosomes - the incentive pushNeoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumabThe network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancerMolecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case PresentationBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityMatrix control of transforming growth factor-β functionWithania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transitionNon-muscle myosin IIB is critical for nuclear translocation during 3D invasion.Neuraminidase-1: a novel therapeutic target in multistage tumorigenesisThe transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancerIdentification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTIncreased cancer stem cell invasion is mediated by myosin IIB and nuclear translocationInvolvement of Ras GTPase-activating protein SH3 domain-binding protein 1 in the epithelial-to-mesenchymal transition-induced metastasis of breast cancer cells via the Smad signaling pathway.Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion.Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer.STAT3 and epithelial-mesenchymal transitions in carcinomasTwo faces of TGF-beta1 in breast cancer.CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples.Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cellsThe epigenetics of epithelial-mesenchymal plasticity in cancer.Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell lineSurfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasisIncreased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.The RhoGEF Net1 is required for normal mammary gland development.Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancerLoss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.Modeling TGF-β in early stages of cancer tissue dynamics.Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection.HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancerDeptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expressionEya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.TGFβ and BMP-2 regulate epicardial cell invasion via TGFβR3 activation of the Par6/Smurf1/RhoA pathway.
P2860
Q24313363-5C611D0C-31DD-4D5E-9FC1-127EEADBD1A2Q26739625-03F6B24A-6173-4CF0-8941-CA6C5EEED181Q26741215-2BA736F9-F979-4EC9-9BA5-29807D9FBDA8Q26764879-90BAC470-23D7-4551-A998-0CCC1D00C07FQ26785448-FA6E6E46-1C26-4BAD-A1FA-67964DDB41EBQ26800626-AADC207C-BDB1-415F-A87C-846AA08B0DD1Q26851620-BFD25810-1322-42DF-9089-6F3C5CB2D194Q27002535-AC0DAB79-1592-4AAA-ACDD-CBFF62059943Q27305726-E37416AF-EB8C-4187-BF49-C9C01B1D5C33Q27310111-33EEC00D-3CAC-4789-8CD6-A2CD837F5E67Q28066130-FAD366D6-B785-4924-BDA4-B0614BA7F391Q28743642-8EB485AE-405A-4893-A9D0-286CCEEE87D7Q28744173-821BEEA1-FA29-4606-9227-238BC5F85CFBQ28917147-E396324A-BD84-434C-BBE6-0310224CBD1FQ30009174-3D83A6A1-1CA7-46A8-B618-B381EFACD6F0Q30502431-06CEA32A-45AE-4840-AEB9-DFAB74875B01Q30597668-2694B982-2B95-4BE8-87F3-76E2D77022B2Q33607424-80E9AFC3-2FC9-423F-ACB7-A944FBEB8E55Q33623947-C8D369D1-1FA5-49ED-9190-F1553EF0503EQ33661529-A6C9A609-22D4-447E-83C0-60D4B4DA8945Q33721133-306027F9-CDCA-4285-ACED-ABB0CB5556D9Q33859309-245AAF7A-5FFF-4CAC-B11F-74DBA94E5EC1Q33865464-449FBA6C-3499-4105-A909-AECC054B99A6Q34310378-CD481B98-D6AC-419F-8C6F-8A1E8593E582Q34366588-802877D0-F24E-4190-8432-19AEF232756AQ34391559-739B7C2D-7F0C-4C53-B31D-633015E81B91Q34404867-683B30DD-D39D-4AC3-A70F-884CF8C65762Q34603102-F4A0E976-F893-4242-9B7D-6AA799D23DDFQ34606919-1A5C13B4-D11F-4DF4-9A85-A8D859BE654EQ34614133-69002EB1-B095-4CAA-A508-0A0B94F45C54Q34708273-73F1A798-5B80-42D7-BC36-D4BBD5074654Q35106118-1FD0E170-58E7-44CE-A734-6A86B3689655Q35112032-E7F031F5-4022-455A-BA96-327896973D32Q35155602-026E8458-21BE-421F-807F-777046CABF46Q35177151-A05FEB51-6682-480B-A890-DA0D99ACADD2Q35214539-E946E5E2-FF1E-4280-AC9A-333995B516BFQ35243673-CBA61751-EA83-4514-BB9F-DE33CA07A9AFQ35490960-418C30A0-A304-495D-9D8F-18CCBA16F340Q35558027-716F0FC7-DF97-4FE5-9F99-C5849BA86A67Q35613300-D7D77398-C65C-4A78-B330-F4001F7A8868
P2860
The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The pathophysiology of epithel ...... nant mammary epithelial cells.
@en
The pathophysiology of epithel ...... nant mammary epithelial cells.
@nl
type
label
The pathophysiology of epithel ...... nant mammary epithelial cells.
@en
The pathophysiology of epithel ...... nant mammary epithelial cells.
@nl
prefLabel
The pathophysiology of epithel ...... nant mammary epithelial cells.
@en
The pathophysiology of epithel ...... nant mammary epithelial cells.
@nl
P2093
P2860
P1476
The pathophysiology of epithel ...... nant mammary epithelial cells.
@en
P2093
Jenny G Parvani
Molly A Taylor
William P Schiemann
P2860
P2888
P304
P356
10.1007/S10911-010-9181-1
P577
2010-05-15T00:00:00Z